168 results
8-K
EX-99.1
GILD
Gilead Sciences, Inc.
25 Apr 24
Gilead Sciences Announces First Quarter 2024 Financial Results
4:04pm
Capital and CNBC, reflecting Gilead’s longstanding commitment to operate responsibly.
The Board declared a quarterly dividend of $0.77 per share
8-K
EX-99.1
GILD
Gilead Sciences, Inc.
22 Mar 24
Gilead Sciences Announces Completion of Acquisition of Cymabay
9:21am
portfolio and aligns with its long-standing commitment to bringing transformational medicines to patients.
“The acquisition of CymaBay brings us … and Chief Executive Officer, Gilead Sciences. “I want to thank the CymaBay team for their efforts and commitment to addressing this high unmet need. We
SC TO-T
EX-99
s8bg kz4ufu
23 Feb 24
Third party tender offer statement
6:09am
SC TO-C
EX-99.1
3y6xzarrgi
14 Feb 24
Information about tender offer
5:08pm
SC TO-C
EX-99.1
r61okoc b2j2
12 Feb 24
Information about tender offer
4:14pm
SC TO-C
EX-99.2
fktrd1lvujt37puyyx
12 Feb 24
Information about tender offer
4:14pm
SC TO-C
EX-99.3
o3mre21qju
12 Feb 24
Information about tender offer
4:14pm
SC TO-C
EX-2.1
kgbonqq4
12 Feb 24
Information about tender offer
8:39am
SC TO-C
EX-99.1
8sa1it3e
12 Feb 24
Information about tender offer
8:39am
8-K
EX-2.1
oui1smfykav8sp kuhw
12 Feb 24
Entry into a Material Definitive Agreement
8:37am
8-K
EX-99.1
breav2 x1v1r9
12 Feb 24
Entry into a Material Definitive Agreement
8:37am
8-K
EX-99.1
2rq4fqs
6 Feb 24
Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results
4:04pm
8-K
EX-1.1
stscdf6pmrfy5h3mdp
14 Sep 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-99.1
bz2rjecz rhdlghd
16 Aug 23
Regulation FD Disclosure
5:19pm